Free Trial

Aquestive Therapeutics (AQST) SEC Filings & 10K Form

Aquestive Therapeutics logo
$3.10 +0.01 (+0.32%)
As of 01/17/2025 04:00 PM Eastern

Recent Aquestive Therapeutics SEC Filings

DateFilerForm TypeView
01/13/2025
6:07 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:02 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:40 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:42 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
7:05 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
7:06 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/16/2024
4:16 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
1:14 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4/A
10/02/2024
1:16 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4/A
09/27/2024
7:46 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:56 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
1:45 PM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:26 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
7:16 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:32 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:14 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3/A
06/11/2024
11:35 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2024
11:36 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:13 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
12:40 PM
Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
12:40 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
8:08 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:21 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:23 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
8:30 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
8:20 AM
Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2024
5:23 AM
Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/24/2024
5:25 AM
Aquestive Therapeutics (Filer)
Aquestive Therapeutics (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/23/2024
11:15 PM
Aquestive Therapeutics (Filer)
Form EFFECT
04/03/2024
4:27 PM
Aquestive Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.

04/01/2024
5:21 PM
Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
04/01/2024
7:15 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
1:30 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:56 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
12:45 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:46 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:46 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
12:47 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:34 AM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:35 AM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
9:36 AM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:09 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
4:12 PM
Aquestive Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
2:24 PM
Aquestive Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AQST) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners